Long-term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5-fluorouracil vs docetaxel, cisplatin, and 5-fluorouracil followed by surgery for esophageal cancer (OGSG1003).

Keijiro SugimuraMakoto YamasakiTakushi YasudaMasahiko YanoMotohiro HiraoKazumasa FujitaniYutaka KimuraHiroshi MiyataMasaaki MotooriAtsushi TakenoOsamu ShiraishiTomoki MakinoTakayuki KiiKoji TanakaTaro SatohMasaki MoriYuichiro Doki

Published in: Annals of gastroenterological surgery (2020)

Cisplatin and fluorouracil plus docetaxel are associated with better RFS and OS than ACF in resectable ESCC patients.

Keyphrases

locally advanced
end stage renal disease
rectal cancer
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
coronary artery bypass